Medicine & Life Sciences
Glucose
100%
Peptides
87%
gastric inhibitory polypeptide receptor
81%
Glucagon-Like Peptide 1
70%
xenin 25
66%
Hypoglycemic Agents
54%
Insulin
51%
Fats
50%
Gastric Inhibitory Polypeptide
38%
Obesity
37%
Glucagon-Like Peptide-1 Receptor
36%
Insulin Secretion
36%
Glucagon
33%
Pro(3)-glucose-dependent insulinotropic polypeptide
33%
Islets of Langerhans
33%
Incretins
29%
Insulin Resistance
28%
Exenatide
27%
Glucagon Receptors
25%
cholecystokinin 8
24%
pro-glucose-dependent insulinotropic polypeptide
22%
Oxyntomodulin
22%
Dipeptidyl Peptidase 4
21%
xenin-8
20%
Streptozocin
20%
Homeostasis
20%
Cell Transdifferentiation
19%
Insulin-Secreting Cells
19%
Hormones
18%
Type 2 Diabetes Mellitus
17%
Body Weight
17%
Peptide YY
16%
Therapeutics
16%
Cholecystokinin
15%
Bone and Bones
13%
peptide YY (1-36)
12%
Injections
11%
Liraglutide
11%
Cell Survival
10%
Cholecystokinin Receptors
10%
High Fat Diet
10%
Sitagliptin Phosphate
10%
Eating
9%
glucagon-like peptide 1 (7-36)amide
9%
exendin (9-39)
9%
Energy Intake
8%
D-Ser2-oxyntomodulin
8%
Peptide Fragments
8%
peptide YY (3-36)
8%
Gastrins
8%
Chemistry
Insulinotropic
91%
Insulin Derivative
68%
Glucose
46%
Polypeptide
44%
Fat
29%
Glucagon-Like Peptide 1
27%
Glucagon
26%
Metabolic
23%
Peptide
22%
Exendin-4
13%
Plasma
12%
Agent Interacting With Transmitter, Hormone or Drug Receptor
12%
Peptide YY
12%
Twice Daily
11%
Ablation
11%
Hormone
11%
Oxyntomodulin
10%
Glucagon Receptor Antagonist
10%
Antidiabetic Agent
9%
Glycemic
9%
Weight
8%
Food
8%
Gastrointestinal Hormone
8%
Incretin Mimetic
7%
Bioactivity
7%
Neurotensin
7%
Agonist
7%
Obestatin
7%
Intraperitoneal
7%
Once Daily
5%